Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical polyacrylonitrile fiber for preventing and curing mammary gland hyperplasia, preparation and application thereof

A polyacrylonitrile fiber and mammary gland hyperplasia technology, which is applied in the field of medicinal fibers, can solve problems such as strong odor, and achieve the effects of simple production process, rich source of raw materials, and convenient medication

Active Publication Date: 2007-02-28
义乌市宏光针织有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The purpose of the present invention is to: provide a kind of medicinal polyacrylonitrile fiber, to overcome the defect that the existing medicinal fabric has a big smell

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The first step is to prepare spinning dope. Firstly, a spinning dope containing polyacrylonitrile was prepared according to an existing process, wherein the dry solid content A of polyacrylonitrile was 99 parts by weight. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. The solid content C is 0.5 parts by weight;

[0026] In the second step, the spinning stock solution containing the anti-mammary gland hyperplasia drug and the drug transdermal absorption accelerator is made into medicinal polyacrylonitrile fiber, and the wet spinning process, the dry spinning process or the dry jet wet spinning process can be used , the prepared medicinal polyacrylonitrile fiber not only contains polyacrylonitrile, but also contains drugs for preventing and treating mammary gland hyperplasia and drug transdermal absorption accelerators;

[0027] The prepa...

Embodiment 2

[0033] In the present embodiment, the dry solid content A of polyacrylonitrile in the spinning dope is 80 parts by weight, the dry solid content B of the drug for preventing and treating mammary gland hyperplasia is 15 parts by weight, and the dry solid content C of the drug transdermal absorption accelerator is 5 parts by weight Parts, other methods are the same as in Example 1.

Embodiment 3

[0035] In the present embodiment, the dry solid content A of polyacrylonitrile in the spinning dope is 70 parts by weight, the dry solid content B of the drug for preventing and treating mammary gland hyperplasia is 20 parts by weight, and the dry solid content C of the drug transdermal absorption accelerator is 10 parts by weight Parts, other methods are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medical polyacryl-nitrile fiber for treating mammary gland proliferation, relative preparation and application, wherein the polyacryl-nitrile is at 60-99 deals; the drug is 0-30 deals; and the drug transdermal adsorption accelerant is 0-10 deals; said drug is one or the mixture of tamoxifen, isoflavone, etc; said drug transdermal adsorption accelerant is one or mixture of oleic acid, N- methyl-2- pyrrolidone, methyl glycol and baras camphor. The invention has simple method, lower cost, and lower side effect.

Description

technical field [0001] The invention relates to a medicinal fiber, especially a medicinal polyacrylonitrile fiber for preventing hyperplasia of mammary glands, its manufacturing method and application. Background technique [0002] Mammary gland hyperplasia is the most common breast disease, and its incidence rate accounts for the first place in breast diseases. For the treatment of mammary gland hyperplasia, traditional Chinese medicine generally takes orally or externally applies some traditional Chinese medicines that soothe the liver, regulate qi, activate blood and remove blood stasis; Western medicine uses hormone drugs or surgical treatment. The effect of traditional Chinese medicine treatment of this disease is better, but the oral treatment of traditional Chinese medicine is loaded down with trivial details because of boiling medicine, and the medication time is long, and the patient is difficult to adhere to, and the curative effect of western medicine treatment of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): D01F6/18D01F1/10D01D5/06A61K9/00A61K31/138A61K31/352A61K31/4985A61K31/58A61P15/14A61M37/00
Inventor 朱利民克雷斯·布兰福特-怀特樊在霞
Owner 义乌市宏光针织有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com